Roy P.C. Kessels: Stroke’s Cognitive Impact on Young Adults Is Significant and Often Overlooked
Roy P.C. Kessels, Full Professor at Radboud University, Clinical Neuropsychologist at Vincent van Gogh Institute for Psychiatry, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Stroke doesn’t just affect older adults; its cognitive impact on young adults is significant and often overlooked.
In a review paper just published in Trends in Neurosciences, we provide an overview on the state of the art on the neural mechanisms underlying these impairments and the future challenges.
The highlights:
- Cognitive impairment is common after stroke in younger populations
- Recovery paths vary widely: some improve, while others face delayed cognitive decline months later
- It’s not just localized brain damage; disruption across broader brain networks plays a key role
- Brain resilience, through reserve, adaptability, and compensation, may help explain why outcomes differ
- There’s a clear and urgent need for evidence-based cognitive rehabilitation tailored specifically to young stroke survivors
The takeaway: we need to move beyond a one-size-fits-all approach and invest in personalized, long-term cognitive care strategies for younger patients.
With the Radboudumc stroke research group at the department of neurology: Hao Li, Mijntje Schellekens, Frank-Erik de Leeuw and Anil Man Tuladhar, and Vitória Piai and me from the Neuropsychology and Rehabilitation Psychology department at the Donders Institute for Brain, Cognition, and Behaviour.”
Title: Cognitive performance after stroke at a young age from a brain network perspective
Authors: Hao Li, Mijntje Schellekens, Vitória Piai, Roy Kessels, Frank-Erik de Leeuw, Anil Tuladhar
Read the Full Article on Trends in Neurosciences

Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications